Zoetis Revenue and Competitors
Estimated Revenue & Valuation
- Zoetis's estimated annual revenue is currently $7.6B per year.
- Zoetis's estimated revenue per employee is $642,225
- Zoetis's total funding is $40M.
- Zoetis's current valuation is $97.5B. (January 2022)
Employee Data
- Zoetis has 11865 Employees.
- Zoetis grew their employee count by 5% last year.
Zoetis Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10501.6M | 52247 | 6% | N/A | N/A |
What Is Zoetis?
Pfizer Animal Health Global Poultry is a leader in the poultry industry globally in our commitment to research and development. We are committed to developing and commercializing novel therapeutic, mechanical and data management products which continue to provide increasing value to the global poultry health industry. As Pfizer Global Poultry has expanded over the years, we have added depth in our ability to deliver reliable service, intimate industry knowledge and sophisticated device design.
keywords:N/A$40M
Total Funding
11865
Number of Employees
$7.6B
Revenue (est)
5%
Employee Growth %
$97.5B
Valuation
N/A
Accelerator
Zoetis News
Analysts expect Zoetis to post earnings of $1.22 per share for the quarter. Zoetis has set its FY 2022 guidance at $5.090-$5.190 EPS and its...
The Zoetis Foundation has selected grantees that will provide greater access to education and mental wellness resources, expand veterinary...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Mar 31, 2022--. Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb 24, 2021-- Zoetis Inc. (NYSE:ZTS) will participate in the Cowen 41 st Annual Health Care Conference on Monday, March 1, 2021. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to pres ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 13173 | 15% | N/A |
#2 | $5082.1M | 15656 | -1% | $3.2B |
#3 | $8100M | 15750 | 2% | $418.3M |
#4 | N/A | 18020 | 1% | N/A |
#5 | $6703.7M | 19077 | 18% | N/A |